Chronic Kidney Disease

Why is this man gaining weight, instead of losing it, while taking a natural supplement?

Of 400 dialysis patients with the Vall d’Hebron University Hospital as reference in Barcelona, Spain, 21 contracted the coronavirus disease 2019 (COVID-19) and the mortality rate in this center was 24%, according to the opening presentation at the ERA-EDTA Congress conference.

Previous clinical trials have shown that SGLT2 inhibitors protect kidney, or renal, function among patients with T2D, but their effect on serious renal events in patients in real-world clinical practice remains unclear.

Study shows sleep apnea is significantly associated with increased risk of death among patients with advanced chronic kidney disease (CKD) and end-stage renal disease.

The new guidelines recommend dosing vancomycin to achieve an area under the curve to minimum inhibitor concentration (AUC/MIC) ratio of ≥ 400.

Excessive alcohol consumption can damage the liver, thereby increasing the load on the kidneys to filter the blood stream.

Top news of the week across the healthcare landscape.

Top news from across the health care landscape.

Todd Brothers, PharmD, BCCCP, BCPS, clinical assistant professor, University of Rhode Island, discusses what patients should know about medications that cause hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

Through the Automatic LifeStyle Advice platform, health service providers can integrate personal health trackers, allowing data to configure the optimal recommendation for diet, exercise, and daily health management.

Study findings presented at the American Society of Nephrology’s Kidney Week 2019 suggest a link between chronic use of proton pump inhibitors and progression of kidney function decline in chronic kidney disease.

Baclofen use, particularly at higher doses, may result in an increased risk of encephalopathy among patients with chronic kidney disease.

Todd Brothers, PharmD, BCCCP, BCPS clinical assistant professor, University of Rhode Island, discusses the role of pharmacists in assessing patients for hyperkalemia and in managing those with a chronic condition. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

Patients with HIV who are diagnosed with chronic kidney disease have a higher burden of serious clinical events.

Jaclyn Harth, PharmD, clinical assistant professor, Fairleigh Dickinson School of Pharmacy, discusses the role of the health system pharmacist for patients with chronic hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.

A recent study showed that effective lifestyle behavioral changes for patients with chronic kidney disease frequently involved education, goal setting, feedback, monitoring, and social support.

A retrospective cohort study was the second largest evaluation to date of sodium polystyrene sulphonate use and safety in patients with chronic kidney disease.

A study using genomics and proteomics identified new subtypes of clear cell renal cell carcinoma based on tumor microenvironment signatures.

More men than women initiate kidney replacement therapy despite a higher prevalence of chronic kidney disease seen in women.

A study published in the Clinical Journal of American Society of Nephrology found that a healthy dietary pattern may prevent chronic kidney disease (CKD) and albuminuria.

A recent study suggests that hyperkalemia and uncomplicated hyperglycemia in patients treated in the emergency department is commonly caused by iatrogenesis.

Neither vitamin D nor omega-3 fatty acid supplementation were found to significantly inhibit changes in serum creatinine and cystatin C decline over 5 years among adults with type 2 diabetes.

Roxadustat for the treatment of patients with anemia from chronic kidney disease was shown to have positive efficacy and no increased cardiovascular risk in patients dependent and not dependent on dialysis.

The oral therapy is indicated to act as both a monotherapy and a combination therapy to improve glycemic control. It is also indicated to prevent cardiovascular and renal death in patients with CKD.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than 661,000 Americans have kidney failure.

According to the CDC, approximately 1 of 3 patients with type 1 and 2 diabetes mellitus (DM) has CKD. What do we need to know about patients with DM and CKD?

High consumption of sugary beverages has previously been linked to obesity, diabetes, and some types of cancer.

A multimethod approach including use of refill data may be the most effective method to identify nonadherence in young patients with chronic kidney disease.

In an additional analysis from the CANVAS program, new data reinforce evidence of improved renal outcomes for those with type 2 diabetes and chronic kidney disease.

Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.